What is scabies and what are the recommended first‑line and alternative treatments, including dosing, repeat therapy, and special considerations for children, pregnant or lactating women, and household contacts?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Scabies: Disease Overview and Treatment

What is Scabies?

Scabies is a highly contagious skin infestation caused by the parasitic mite Sarcoptes scabiei var. hominis, characterized by intense pruritus (especially nocturnal) and a distinctive papular rash with burrows. 1, 2

  • The predominant symptom is pruritus, which develops several weeks after initial sensitization to the mite, but may occur within 24 hours after subsequent reinfestations. 1
  • Classic lesions include serpiginous burrows, erythematous papules, and secondary excoriations from scratching. 3
  • Predilection sites include finger webs, wrists, axillary folds, waist, abdomen, buttocks, genitals, and inframammary folds. 3
  • Scabies affects over 200 million individuals worldwide and is recognized by the WHO as a neglected tropical disease. 2

First-Line Treatment

Permethrin 5% cream is the recommended first-line treatment for scabies across all age groups. 1, 4, 5

Application Protocol:

  • Apply to all areas of the body from the neck down and wash off after 8-14 hours (typically overnight application). 1, 5
  • A single application is generally curative for uncomplicated scabies. 4, 5
  • Permethrin is effective, safe, and has minimal toxicity compared to alternatives. 1

Alternative Treatment: Oral Ivermectin

Oral ivermectin 200 μg/kg is an effective alternative, with a repeat dose required after 2 weeks. 4, 5

Critical Administration Details:

  • Must be taken with food to ensure adequate bioavailability and epidermal penetration. 4, 5
  • The two-dose schedule addresses ivermectin's limited ovicidal activity. 4
  • Particularly useful in institutional outbreaks or when topical application is impractical. 4

Contraindications:

  • Contraindicated in children weighing < 15 kg or younger than 10 years due to potential blood-brain barrier penetration and neurotoxicity. 4, 6
  • Should be avoided in pregnant or lactating women due to insufficient safety data. 4, 5

Age-Specific Application Guidelines

Infants and Young Children (≤ 2 years):

  • Apply permethrin to the entire body, including scalp, hairline, forehead, temples, and neck—not just neck-down as in adults. 4
  • Permethrin is the only recommended agent for this age group. 4

Children ≥ 10 years (or ≥ 15 kg):

  • May apply permethrin from neck down only, unless immunocompromised. 4
  • Oral ivermectin becomes an option at this weight threshold. 4

Special Populations

Pregnant or Lactating Women:

  • Permethrin 5% cream is the only recommended treatment. 1, 4, 5
  • Ivermectin lacks sufficient safety data in pregnancy. 4

Crusted (Norwegian) Scabies:

This severe variant requires aggressive combination therapy and specialist consultation. 4, 5

  • Topical permethrin 5% cream applied daily for 7 days, then twice weekly until cure. 4, 5
  • Plus oral ivermectin 200 μg/kg on days 1,2,8,9, and 15. 4, 5
  • Single-agent therapy will fail due to massive mite burden (thousands to millions of mites). 4
  • Occurs primarily in immunocompromised, debilitated, or malnourished individuals. 4

Alternative Topical Agents (When Permethrin Unavailable or Fails)

Sulfur 6% Ointment:

  • Apply nightly for 3 consecutive nights; wash off previous application before reapplying. 1
  • Thoroughly wash off 24 hours after the last application. 1

Lindane 1%:

  • Apply thinly from neck down and wash off after 8 hours. 1
  • Critical contraindications and warnings:
    • Never use in children < 10 years, pregnant/lactating women, or persons with extensive dermatitis. 1, 4, 5
    • Never apply after bathing—increases systemic absorption and risk of seizures. 1, 5
    • Seizures and aplastic anemia have been reported with improper use. 1
    • Resistance has been documented in some geographic areas. 1

Contact and Environmental Management

Simultaneous treatment of all contacts is mandatory to prevent reinfection—this is the most common cause of treatment failure. 4, 5, 6

Who to Treat:

  • All household members, close personal contacts, and sexual partners within the preceding month must be treated simultaneously, even if asymptomatic. 1, 4, 5

Environmental Decontamination:

  • Machine-wash and dry all bedding, clothing, and towels on hot cycles, or dry-clean. 1, 4, 5
  • Alternatively, isolate items from skin contact for ≥ 72 hours—mites cannot survive off-host longer than this. 1, 4
  • Fumigation of living areas is not required. 1, 4, 5

Post-Treatment Course and Retreatment Criteria

Pruritus and rash may persist for up to 2 weeks after successful therapy due to allergic dermatitis—this does NOT indicate treatment failure. 4, 5, 6

When to Retreat:

  • Retreatment is indicated only after 2 weeks if:
    • Live mites are observed on examination. 4, 5
    • Symptoms persist beyond 2 weeks. 4, 5
    • New lesions continue to appear. 4
  • Use an alternative regimen (switch between permethrin and ivermectin) if retreatment is needed. 4, 5

Common Pitfall:

  • Avoid premature retreatment within the first 2 weeks based solely on persistent itching. 4

Institutional Outbreak Management

During outbreaks in nursing homes, hospitals, or residential facilities, treat the entire at-risk population concurrently. 1, 4

  • Mass oral ivermectin is recommended for ease of administration. 4
  • Outbreak response should involve specialist consultation to coordinate treatment and control measures. 1, 4

Critical Treatment Pitfalls to Avoid

  • Failure to treat asymptomatic contacts simultaneously is the leading cause of reinfection and treatment failure. 4, 6
  • Not repeating ivermectin dose at 2 weeks allows mite eggs to hatch and reinfestation to occur. 6
  • Applying lindane after bathing dramatically increases systemic absorption and neurotoxicity risk. 1, 5
  • Using lindane in contraindicated populations (children < 10 years, pregnant women, extensive dermatitis) risks seizures and aplastic anemia. 1, 4, 5
  • Inadequate topical application—must cover all body surfaces from neck down, including under nails and body folds. 4
  • Expecting immediate symptom resolution—post-treatment pruritus lasting up to 2 weeks is normal. 4, 5

Adjunctive Symptomatic Management

Topical corticosteroids (e.g., triamcinolone) should only be considered if pruritus persists beyond 2 weeks AND after confirming no live mites are present. 5

  • Do not apply corticosteroids during active treatment—they suppress inflammatory response needed to identify active infestation and may allow mites to proliferate. 5
  • Use limited application to affected areas only to minimize risks of skin atrophy and pigmentary changes. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Scabies: A Neglected Global Disease.

Current pediatric reviews, 2020

Guideline

Scabies Management in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Scabies Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Tratamiento Médico de la Escabiosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.